Curis, Inc. ("Curis") (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, yesterday presented data ...

'It only got more surreal': Anderson Cooper on Trump's makeshift Tesla showroom at the White House ...

“This is a big project that’s being proposed, but I think it’s something that could be really a game changer for our community,” City Administrator Scott Coker told city council members during ...